130 related articles for article (PubMed ID: 33093330)
1. Cost-Effectiveness of HRSA's Ryan White HIV/AIDS Program?
Goyal R; Luca D; Klein PW; Morris E; Mandsager P; Cohen SM; Hu C; Hotchkiss J; Gao J; Jones A; Addison W; O'Brien-Strain M; Cheever LW; Gilman B
J Acquir Immune Defic Syndr; 2021 Feb; 86(2):174-181. PubMed ID: 33093330
[TBL] [Abstract][Full Text] [Related]
2. The Health Resources and Services Administration's Ryan White HIV/AIDS Program in rural areas of the United States: Geographic distribution, provider characteristics, and clinical outcomes.
Klein PW; Geiger T; Chavis NS; Cohen SM; Ofori AB; Umali KT; Hauck H
PLoS One; 2020; 15(3):e0230121. PubMed ID: 32203556
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model to estimate the state-specific impact of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
Klein PW; Cohen SM; Uzun Jacobson E; Li Z; Clark G; Fanning M; Sterling R; Young SR; Sansom S; Hauck H
PLoS One; 2020; 15(6):e0234652. PubMed ID: 32569330
[TBL] [Abstract][Full Text] [Related]
4. Methodology for linking Ryan White HIV/AIDS Program Services Report (RSR) client level data over multiple years.
Zhu J; Fanning M; Sheehan L; Morrissey KG; Legum S; Hermansen S
PLoS One; 2020; 15(8):e0237635. PubMed ID: 32823269
[TBL] [Abstract][Full Text] [Related]
5. Service Delivery and Patient Outcomes in Ryan White HIV/AIDS Program-Funded and -Nonfunded Health Care Facilities in the United States.
Weiser J; Beer L; Frazier EL; Patel R; Dempsey A; Hauck H; Skarbinski J
JAMA Intern Med; 2015 Oct; 175(10):1650-9. PubMed ID: 26322677
[TBL] [Abstract][Full Text] [Related]
6. The health equity implications of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
Goyal R; Hotchkiss J; Gilman B; Klein PW; Mills RJ; Starling J; Martin NK; Patton T; Cohen SM; Cheever L
AIDS; 2024 Jun; 38(7):1025-1032. PubMed ID: 38691049
[TBL] [Abstract][Full Text] [Related]
7. HIV-related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the Health Resources and Services Administration's Ryan White HIV/AIDS Program: A retrospective study.
Klein PW; Psihopaidas D; Xavier J; Cohen SM
PLoS Med; 2020 May; 17(5):e1003125. PubMed ID: 32463815
[TBL] [Abstract][Full Text] [Related]
8. Development of a Mathematical Model to Estimate the Cost-Effectiveness of HRSA's Ryan White HIV/AIDS Program.
Goyal R; Hu C; Klein PW; Hotchkiss J; Morris E; Mandsager P; Cohen SM; Luca D; Gao J; Jones A; Addison W; O'Brien-Strain M; Cheever LW; Gilman B
J Acquir Immune Defic Syndr; 2021 Feb; 86(2):164-173. PubMed ID: 33109934
[TBL] [Abstract][Full Text] [Related]
9. The Ryan White HIV/AIDS Program: Supplementary Service Provision Post-Affordable Care Act.
Kay ES; Batey DS; Mugavero MJ
AIDS Patient Care STDS; 2018 Jul; 32(7):265-271. PubMed ID: 29985648
[TBL] [Abstract][Full Text] [Related]
10. Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes.
Bradley H; Viall AH; Wortley PM; Dempsey A; Hauck H; Skarbinski J
Clin Infect Dis; 2016 Jan; 62(1):90-98. PubMed ID: 26324390
[TBL] [Abstract][Full Text] [Related]
11. Reducing HIV-Related Health Disparities in the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
Mandsager P; Marier A; Cohen S; Fanning M; Hauck H; Cheever LW
Am J Public Health; 2018 Nov; 108(S4):S246-S250. PubMed ID: 30383416
[TBL] [Abstract][Full Text] [Related]
12. The Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program's Response to the Opioid Epidemic.
Chavis NS; Klein PW; Cohen SM; Dempsey A; Hauck H; Cheever LW
J Infect Dis; 2020 Sep; 222(Suppl 5):S477-S485. PubMed ID: 32877537
[TBL] [Abstract][Full Text] [Related]
13. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
Abramowitz S; Greene D
AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
[TBL] [Abstract][Full Text] [Related]
14. The Ryan White HIV/AIDS Program after the Patient Protection and Affordable Care Act full implementation: a critical review of predictions, evidence, and future directions.
Ginossar T; Oetzel J; Van Meter L; Gans AA; Gallant JE
Top Antivir Med; 2019 Sep; 27(3):91-100. PubMed ID: 31634860
[TBL] [Abstract][Full Text] [Related]
15. Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act.
Berry SA; Fleishman JA; Yehia BR; Cheever LW; Hauck H; Korthuis PT; Mathews WC; Keruly J; Nijhawan AE; Agwu AL; Somboonwit C; Moore RD; Gebo KA;
Clin Infect Dis; 2016 Aug; 63(3):387-95. PubMed ID: 27143660
[TBL] [Abstract][Full Text] [Related]
16. Coordinating Care for People With HIV Who Have Lower Incomes and Alternative Sources of Health Care Coverage.
Au M; Coombs E; Jones A; Carley F; Talwar-Hebert M; Addison W; Mills RJ; Cohen SM; Klein PW; Cheever L; Gilman B
J Assoc Nurses AIDS Care; 2023 May-Jun 01; 34(3):280-291. PubMed ID: 37098817
[TBL] [Abstract][Full Text] [Related]
17. Unmet needs for HIV ancillary care services by healthcare coverage and Ryan White HIV/AIDS program assistance.
Dasgupta S; Crim SM; Dawson L; Kates J; Weiser J; Klein PW; Dempsey A; Hauck H; Lu JF; Shu F; Beer L
AIDS; 2022 Aug; 36(10):1399-1407. PubMed ID: 35212670
[TBL] [Abstract][Full Text] [Related]
18. Ryan White HIV/AIDS Part B and AIDS Drug Assistance Programs during COVID-19: safety net public health programs' challenges and innovations.
McManus KA; Strumpf AM; Killelea A; Horn T; Steen A; An Z; Schurman E; Hamp A; Keim-Malpass J
Front Public Health; 2023; 11():1172009. PubMed ID: 37583891
[TBL] [Abstract][Full Text] [Related]
19. High rates of retention and viral suppression in the US HIV safety net system: HIV care continuum in the Ryan White HIV/AIDS Program, 2011.
Doshi RK; Milberg J; Isenberg D; Matthews T; Malitz F; Matosky M; Trent-Adams S; Parham Hopson D; Cheever LW
Clin Infect Dis; 2015 Jan; 60(1):117-25. PubMed ID: 25225233
[TBL] [Abstract][Full Text] [Related]
20. Health information technology interventions and engagement in HIV care and achievement of viral suppression in publicly funded settings in the US: A cost-effectiveness analysis.
Shade SB; Marseille E; Kirby V; Chakravarty D; Steward WT; Koester KK; Cajina A; Myers JJ
PLoS Med; 2021 Apr; 18(4):e1003389. PubMed ID: 33826617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
